Want to see JP:6856 full AI Analyst Report?
6856 Stock Chart & Stats
¥20875.00
¥93.00(1.00%)
At close: 4:00 PM EST
¥20875.00
¥93.00(1.00%)
Day’s Range― - ―
52-Week Range¥10,800.00 - ¥30,100.00
Previous CloseN/A
Volume233.70K
Average Volume (3M)206.28K
Market Cap
¥1.07T
Enterprise Value¥663.91K
Total Cash (Recent Filing)¥153.20B
Total Debt (Recent Filing)¥64.05B
Price to Earnings (P/E)28.4
Beta1.30
Next Earnings
Aug 07, 2026EPS Estimate
208.4Next Dividend Ex-DateN/A
Dividend Yield2.04%
Share Statistics
EPS (TTM)865.19
Shares Outstanding42,233,253
10 Day Avg. Volume261,620
30 Day Avg. Volume206,283
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)1.92
Price to Sales (P/S)2.01
P/FCF Ratio23.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥32,785.71Price Target Upside57.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1,140.96
Revenue Forecast (FY)¥371.01B
Bulls Say, Bears Say
Bulls Say
Diversified End MarketsHoriba's revenue is spread across automotive testing, semiconductor metrology, environmental/process monitoring, scientific instruments and medical diagnostics. This diversification reduces exposure to any single cyclical industry, supports steady aftermarket service demand, and provides multiple secular growth vectors that stabilize revenue over 2–6 month horizons and beyond.
Sustained Margin ProfileConsistently healthy gross and operating margins reflect the high-value, technically differentiated nature of Horiba's instruments and integrated systems, plus recurring parts/services. Such structural margin strength implies pricing power and an installed-base aftermarket that can sustain profitability even if top-line growth moderates, supporting long-term operating cash generation.
Conservative Balance SheetA materially strengthened equity base and low leverage give Horiba financial flexibility to fund R&D, targeted capex, and selective M&A without straining liquidity. Low debt enhances resilience across cycles and preserves optionality to invest in product development and service expansion that drive durable competitive advantage.
Bears Say
Slowing Revenue GrowthRevenue expansion decelerated to roughly 2.9% in 2025 after stronger prior-year gains. Slower top-line momentum reduces operating leverage potential and limits internal funding for incremental R&D or strategic initiatives, making it harder to sustainably lift margins and returns without a recovery in underlying demand or new structural opportunities.
Inconsistent Cash ConversionOperating and free cash flow have shown meaningful year-to-year swings driven by working-capital and investment timing. This uneven cash conversion reduces predictability of free cash available for dividends, buybacks, or M&A, and complicates planning for sustainable shareholder returns and reinvestment over multi-quarter horizons.
Easing Return On EquityROE has declined as equity grew faster than profits, signaling weaker capital efficiency. If returns remain below historical levels, the company may struggle to deliver attractive shareholder returns absent margin expansion, stronger growth, or more disciplined capital allocation to restore earlier profitability metrics.
Horiba News
6856 FAQ
What was Horiba Ltd’s price range in the past 12 months?
Horiba Ltd lowest stock price was ¥10800.00 and its highest was ¥30100.00 in the past 12 months.
What is Horiba Ltd’s market cap?
Horiba Ltd’s market cap is ¥1.07T.
When is Horiba Ltd’s upcoming earnings report date?
Horiba Ltd’s upcoming earnings report date is Aug 07, 2026 which is in 17 days.
How were Horiba Ltd’s earnings last quarter?
Horiba Ltd released its earnings results on May 14, 2026. The company reported ¥206.13 earnings per share for the quarter, beating the consensus estimate of ¥194.2 by ¥11.93.
Is Horiba Ltd overvalued?
According to Wall Street analysts Horiba Ltd’s price is currently Undervalued.
Does Horiba Ltd pay dividends?
Horiba Ltd pays a Semiannually dividend of ¥340 which represents an annual dividend yield of 2.04%. See more information on Horiba Ltd dividends here
What is Horiba Ltd’s EPS estimate?
Horiba Ltd’s EPS estimate is 208.4.
How many shares outstanding does Horiba Ltd have?
Horiba Ltd has 42,233,253 shares outstanding.
What happened to Horiba Ltd’s price movement after its last earnings report?
Horiba Ltd reported an EPS of ¥206.13 in its last earnings report, beating expectations of ¥194.2. Following the earnings report the stock price went up 0.823%.
Which hedge fund is a major shareholder of Horiba Ltd?
Currently, no hedge funds are holding shares in JP:6856
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Horiba Ltd
HORIBA, Ltd. is a company that designs, produces, and supplies a diverse array of instruments and systems for various sectors. Its operations are structured across five key segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductor, and Scientific. Within the Automotive segment, HORIBA provides sophisticated equipment such as automotive emission analyzers, complete emission measurement solutions, drive line test systems, and engine, fuel cell, and battery testing apparatus. This division also develops test systems for components like engines, chassis, powertrains, brakes, and catalysts, in addition to offering vehicle development and testing engineering services, and managing R&D facilities. The Process & Environmental segment specializes in equipment including stack gas analyzers, industrial water quality analysis and examination systems, air pollution analyzers, environmental radiation meters, and other process measurement tools. For the Medical-Diagnostic field, the company offers a range of analyzers covering hematology, CRP, immunology, clinical chemistry, and blood glucose. The Semiconductor Instruments & Systems division focuses on products vital for chip manufacturing, such as mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers, and vaporizers. Finally, the Scientific segment delivers advanced scientific instrumentation, including Raman spectrometers, pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy tools, optical components, various spectrometers and detectors, and gratings. Established in 1945, HORIBA, Ltd. is headquartered in Kyoto, Japan.
6856 Stock 12 Month Forecast
Average Price Target
¥32,785.71
▲(57.06% Upside)